Background Mycobacterium tuberculosis (TB) is a common pathogen worldwide, and it may
cause significant infection after solid organ transplantation (SOT). We reviewed all reported …

Hepatotoxic effects attributable to antituberculosis therapy are considered unique among
drug-related liver problems because almost all first-line antituberculosis medications have …

The diagnosis and treatment of tuberculosis (TB) in organ transplant recipients presents
several challenges. Impediments to rapid and accurate diagnosis may lead to treatment …

Mycobacterium tuberculosis is a ubiquitous organism that infects one-third of the world's
population. In previous decades, access to organ transplantation was restricted to academic …

Involvement of the gastrointestinal tract by tuberculosis (TB) remains a prevalent and
relevant disease entity in certain areas of the world and in certain at‐risk patient populations …

Mycobacterium tuberculosis can cause significant infections in liver transplant candidates
and recipients. Its nonspecific clinical features and prolonged growth time in culture make …

Introduction Tuberculosis (TB) is considered as a serious complication of organ transplant;
therefore, the detection and appropriate treatment of active TB infection is highly …

Mycobacterium tuberculosis infection in transplant recipient... : Current Opinion in Organ
Transplantation Mycobacterium tuberculosis infection in transplant recipients: early diagnosis …

Epidemiology in Latin America In the last 2 decades, the burden of tuberculosis (TB) has
been considerably reduced in Latin America (LA) countries. The estimated absolute number …

The standard antitubercular treatment (ATT), which consists of isoniazid (INH), rifampicin
(RIF), ethambutol, and pyrazinamide (PZA), is the best available treatment for tuberculosis …